55084-66-7 Usage
Description
4-Chloro-2-methylmercaptopyrimidine-5-carboxylic acid chloride is a chlorinated derivative of 2-methylmercaptopyrimidine-5-carboxylic acid, belonging to the class of organic chemicals known as pyrimidine carboxylic acids. It is a colorless to light yellow solid with a pungent odor and is highly reactive with water and other organic compounds. Due to its reactivity, it should be handled with caution and stored in a cool, dry place away from heat and moisture.
Uses
Used in Pharmaceutical Industry:
4-Chloro-2-methylmercaptopyrimidine-5-carboxylic acid chloride is used as an intermediate in the synthesis of pharmaceuticals for its ability to be incorporated into various drug molecules, contributing to the development of new therapeutic agents.
Used in Agrochemical Industry:
4-Chloro-2-methylmercaptopyrimidine-5-carboxylic acid chloride is used as an intermediate in the synthesis of agrochemicals for its potential to be incorporated into compounds that can help protect crops and enhance agricultural productivity.
Check Digit Verification of cas no
The CAS Registry Mumber 55084-66-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,5,0,8 and 4 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 55084-66:
(7*5)+(6*5)+(5*0)+(4*8)+(3*4)+(2*6)+(1*6)=127
127 % 10 = 7
So 55084-66-7 is a valid CAS Registry Number.
55084-66-7Relevant articles and documents
HETEROCYCLIC COMPOUNDS AND USES THEREOF
-
, (2020/10/21)
Heterocyclic compounds as Weel inhibitors are provided. The compounds may find use as therapeutic agents for the treatment of diseases and may find particular use in oncology.
HETEROCYCLIC COMPOUNDS AND USES THEREOF
-
, (2019/04/25)
Heterocyclic compounds as Wee1 inhibitors are provided. The compounds may find use as therapeutic agents for the treatment of diseases and may find particular use in oncology.
HETEROARYL COMPOUNDS AS BTK INHIBITORS AND USES THEREOF
-
Paragraph 00618, (2015/05/06)
The present invention relates to pyridine, pyrimidine, pyrazine, and pyridazine compounds, and pharmaceutically acceptable compositions thereof, useful as BTK inhibitors.